Dandelion Health used its new clinical AI marketplace to analyze real-world data, showing that GLP-1 drugs may help prevent ...
Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.
Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...
Although vaccines already exist to prevent mpox, high prices and the risk of side effects make it difficult to roll them out ...
The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...
The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...
MinervaX and Wacker Biotech announced yesterday that they have entered into a manufacturing agreement for MinervaX’s ...
With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...
The original concerns of the US regulatory agency over the manufacturing of Eli Lilly’s Ebglyss seem to have been resolved, ...
The FDA has granted Orphan Drug and Rare Pediatric Disease Designations to Somite’s cell replacement therapy for the ...
The San Diego-based biotech company Candid Therapeutics has launched with a huge $370 million with the aim to develop T-cell ...
Adaptin Bio has announced that the FDA has given the green light to start phase 1 clinical trials for its program APTN-101 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results